Authors

• Ricardo C. B. de Menezes
• Peter A. Riedell (ORCID: https://orcid.org/0000-0003-2719-0580)
• Francis K. Buadi (ORCID: https://orcid.org/0000-0003-3214-0203)
• Prashant Kapoor (ORCID: https://orcid.org/0000-0002-4342-364X)
• Moritz Binder (ORCID: https://orcid.org/0000-0001-9014-9658)
• Ricardo Parrondo (ORCID: https://orcid.org/0000-0002-9314-9933)
• Asher Chanan-Kahn
• Vivek Kumar Roy (ORCID: https://orcid.org/0000-0002-4831-3650)
• Hanna Sledge
• Caitlin Flott
• Andre Fernandez
• Leif Bergsagel
• Moez Nayyar
• Mustaqeem Siddiqui
• Saurabh Chhabra
• Kanika Yadav
• Taxiarchis Kourelis
• Nelson Leung
• Erin E. Wiedmeier-Nutor
• Yi Lin
• Angela Dispenzieri
• David Dingli
• Wilson I. Gonsalves
• Morie A. Gertz
• Rafael Fonseca
• Sikander Ailawadhi
• Taimur Sher
• Rahma M. Warsame
• Udit Yadav
• Shaji Kumar
• Nadine Abdallah
• Joselle Cook

Institutions

• Jacksonville College (US)
• WinnMed (US)
• Hospital Moinhos de Vento (BR)
• Mayo Clinic in Arizona (US)
• Mayo Clinic in Florida (US)

Publication Details

Journal

Haematologica

Published

2026-03-05

DOI

https://doi.org/10.3324/haematol.2025.300401

Primary Topic

Multiple Myeloma Research and Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Sanofi
• Celgene
• Ionis Pharmaceuticals
• Prothena
• Ascentage Pharma
• Swedish Orphan Biovitrum
• Onyx Pharmaceuticals
• Takeda Oncology
• Pharmacyclics
• Legend Biotech